Jeffrey P. Mornhinweg

Array ( [id] => 8358658 [patent_doc_number] => 20120213814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'MODIFICATION OF RECOMBINANT ADENOVIRUS WITH IMMUNOGENIC PLASMODIUM CIRCUMSPOROZOITE PROTEIN EPITOPES' [patent_app_type] => utility [patent_app_number] => 13/399654 [patent_app_country] => US [patent_app_date] => 2012-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 102 [patent_figures_cnt] => 102 [patent_no_of_words] => 21793 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13399654 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10348917 [patent_doc_number] => 20150233921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'DETECTION OF SUBJECT BIOMARKER DIAGNOSTIC ASSAY FOR DENGUE FEVER AND THE DIFFERENTIATION OF DENGUE HEMORRHAGIC FEVER' [patent_app_type] => utility [patent_app_number] => 13/985507 [patent_app_country] => US [patent_app_date] => 2012-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18107 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985507 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9174348 [patent_doc_number] => 20130316332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'COMBINATION OF BIOMARKERS FOR THE PROGNOSIS OF RESPONSE OR NON-RESPONSE TO AN ANTI-HCV TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/983405 [patent_app_country] => US [patent_app_date] => 2012-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 49119 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8515926 [patent_doc_number] => 20120315335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-13 [patent_title] => 'SELF-ASSEMBLING NANOPARTICLE DRUG DELIVERY SYSTEM' [patent_app_type] => utility [patent_app_number] => 13/352637 [patent_app_country] => US [patent_app_date] => 2012-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9312 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13352637 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8265197 [patent_doc_number] => 20120164628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'AFFINITY CAPTURE OF CIRCULATING BIOMARKERS' [patent_app_type] => utility [patent_app_number] => 13/351166 [patent_app_country] => US [patent_app_date] => 2012-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23061 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13351166 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10857234 [patent_doc_number] => 08883429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-11 [patent_title] => 'Viral diagnostics' [patent_app_type] => utility [patent_app_number] => 13/345334 [patent_app_country] => US [patent_app_date] => 2012-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 24881 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13345334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9107161 [patent_doc_number] => 20130280293 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-24 [patent_title] => 'COMBINATION HEPTAVALENT VACCINE' [patent_app_type] => utility [patent_app_number] => 13/978397 [patent_app_country] => US [patent_app_date] => 2012-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10329 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8903687 [patent_doc_number] => 20130171191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'Compositions and Methods for Enhancing Dendritic Cell Resistance to Bacterial Infection and for Enhancing the Mobility of Dendritic Cells for Dendritic Cell-Based Immunotherapy' [patent_app_type] => utility [patent_app_number] => 13/341289 [patent_app_country] => US [patent_app_date] => 2011-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17353 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13341289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8289280 [patent_doc_number] => 20120177608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-12 [patent_title] => 'PSEUDOMONAS AERUGINOSA BACTERIOPHAGE(S) AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/330744 [patent_app_country] => US [patent_app_date] => 2011-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8926 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13330744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8252425 [patent_doc_number] => 20120156757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-21 [patent_title] => 'PURIFICATION OF IMMUNOGENS USING A NON-POLYSACCHARIDE MATRIX' [patent_app_type] => utility [patent_app_number] => 13/324464 [patent_app_country] => US [patent_app_date] => 2011-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11042 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20120156757.pdf [firstpage_image] =>[orig_patent_app_number] => 13324464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138551 [patent_doc_number] => 20120093823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'HUMAN BINDING MOLECULES CAPABLE OF NEUTRALIZING INFLUENZA VIRUS H5N1 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/315475 [patent_app_country] => US [patent_app_date] => 2011-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 34736 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093823.pdf [firstpage_image] =>[orig_patent_app_number] => 13315475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11389578 [patent_doc_number] => 09550811 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-24 [patent_title] => 'Peptide scaffold design' [patent_app_type] => utility [patent_app_number] => 13/991108 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24400 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13991108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12165350 [patent_doc_number] => 09884109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-06 [patent_title] => 'Compositions and methods' [patent_app_type] => utility [patent_app_number] => 13/989598 [patent_app_country] => US [patent_app_date] => 2011-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 41 [patent_no_of_words] => 25595 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9792249 [patent_doc_number] => 20150004194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'FACILITATOR-DNA COMBINATION VACCINE' [patent_app_type] => utility [patent_app_number] => 14/356414 [patent_app_country] => US [patent_app_date] => 2011-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10475 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14356414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8171337 [patent_doc_number] => 20120107355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'METHOD OF RAPIDLY PRODUCING IMPROVED VACCINES FOR ANIMALS' [patent_app_type] => utility [patent_app_number] => 13/277076 [patent_app_country] => US [patent_app_date] => 2011-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 38123 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107355.pdf [firstpage_image] =>[orig_patent_app_number] => 13277076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950137 [patent_doc_number] => 20130195917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'IMMUNOADJUVANT' [patent_app_type] => utility [patent_app_number] => 13/878918 [patent_app_country] => US [patent_app_date] => 2011-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9584 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13878918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9970692 [patent_doc_number] => 09017695 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => 'Chimeric therapeutics, compositions, and methods for using same' [patent_app_type] => utility [patent_app_number] => 13/272828 [patent_app_country] => US [patent_app_date] => 2011-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 36 [patent_no_of_words] => 50724 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13272828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950113 [patent_doc_number] => 20130195892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'BVDV VACCINE' [patent_app_type] => utility [patent_app_number] => 13/825050 [patent_app_country] => US [patent_app_date] => 2011-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11282 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8441510 [patent_doc_number] => 20120258127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-11 [patent_title] => 'VACCINE PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/228870 [patent_app_country] => US [patent_app_date] => 2011-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 12145 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13228870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807171 [patent_doc_number] => 20120058124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'INFLUENZA VIRUS-NEUTRALIZING ANTIBODY AND SCREENING METHOD THEREFOR' [patent_app_type] => utility [patent_app_number] => 13/198147 [patent_app_country] => US [patent_app_date] => 2011-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 20653 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058124.pdf [firstpage_image] =>[orig_patent_app_number] => 13198147 [rel_patent_id] =>[rel_patent_doc_number] =>)